
Founder and Chairperson
Mr. Refael Barkan brings decades of leadership and expertise in the pharmaceutical and biotechnology sectors. From 1988 to 2014, he established, grew and served as CEO of Aminolab Laboratory, transforming it into one of Israel’s leading analytical laboratories, overseeing its scientific and financial operations. He trained as an associate engineer in electronics and began his career as an inter-department equipment manager at the Faculty of Agriculture, Hebrew University (1975–1988).
Mr. Barkan’s extensive experience has enabled him to build strong relationships and partnerships with key figures in Israel’s pharmaceutical industry. His strategic vision has played a pivotal role in founding and promoting several biotechnology and medical startups, and has now led him to the establishment of Foraviset.

CEO & General Counsel
J.J. is a licensed attorney in Israel and New York, holding an LL.B. and LL.M. from the Hebrew University of Jerusalem, with a specialization in Intellectual Property and Pharmaceutical Sciences. This dual focus has provided J.J. with in-depth knowledge of the regulatory and scientific landscape of the pharmaceutical industry. With over 20 years of experience in corporate law—spanning both litigation and commercial contracts—J.J. has served as a Corporate Law lecturer at the Ono Academic College’s Law Faculty, Israel’s largest law school, for 14 years.
In his extensive career, J.J. has held various roles as a private practitioner, legal counsel, audit committee member, and board director. His expertise spans corporate governance, shareholder relations, and commercial agreements, enhanced by a strong foundation in intellectual property law and hands-on experience in the pharmaceutical sector.
Chief Commercial Officer
Moran Faibish is a strategic marketing leader with over 15 years of global experience in healthcare and tech. Specializing in market penetration for B2B companies, she has a proven track record of driving revenue growth, expanding market share, and building powerful brand identities. With expertise spanning go-to-market strategies, digital marketing, and crisis management, Moran excels at anticipating trends, mitigating risks, and crafting strategies that deliver real results. She holds a B.A. in Psychology, giving her a deep understanding of consumer behavior and brand positioning. A data-driven strategist and seasoned leader, she navigates dynamic global markets with precision—ensuring brands don’t just stand out, but thrive.
Co-Chief Medical Officer
Head of Women's Department & Head of the Endometriosis Center
of the Hadassah Medical Centre,
Ein Carem, Jerusalem
Prof. Dior completed his medical studies at the Hadassah Hebrew University Medical School and pursued an advanced fellowship with the Australasian Gynaecological Endoscopy and Surgery Society in Gynecological Laparoscopy at The Royal Women’s Hospital, Australia’s top institution for women’s health. Under the mentorship of world-renowned surgeons, he developed expertise in complex gynecological procedures. In 2018, Prof. Dior founded the Endometriosis Center at Hadassah Medical Center, where he currently serves as director. He has published nearly 90 scientific papers and received prestigious international awards for his contributions to gynecological surgery.

Co-Chief Medical Officer
Senior Consultant at the Department of
Obstetrics & Gynecology, Carmel Medical Center, Haifa
Dr. Kaufman is a Senior Consultant in the Department of Obstetrics & Gynecology at Carmel Medical Center in Haifa, Israel. He is the founder and director of the Multidisciplinary Center for the Treatment of Endometriosis and leads the Minimally Invasive Gynecological Surgery division at Carmel. Dr. Kaufman co-founded Noga Medical, a premier private center for excellence in gynecological and women’s surgical care. He also serves as a Clinical Lecturer at the Technion – Israel Institute of Technology and consults for several medical device startups, including Gynica, Ark Surgical, and MST. Dr. Kaufman is a board member of the Asian Society of Endometriosis and Adenomyosis (ASEA).
Foraviset